UGT1A1*28 POLYMORPHISM AND VOMITING IN ADVANCED COLORECTAL CANCER

被引：0
|
作者：
El Bastawisy, A. E. [1 ]
Farid, S. F. [2 ]
Bahnasy, A. A. [1 ]
El Zeiny, A. M. [1 ]
机构：
[1] Cairo Univ, Natl Canc Inst, Med Oncol Dep, Giza, Egypt
[2] Cairo Univ, Fac Pharm, Giza, Egypt
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt459.153
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain
    Bravo-Gomez, Adrian
    Salvador-Martin, Sara
    Zapata-Cobo, Paula
    Sanjurjo-Saez, Maria
    Lopez-Fernandez, Luis Andres
    PHARMACEUTICS, 2022, 14 (10)
  • [22] Polymorphisms in UGT1A1 and UGT1A7 may predict irinotecan toxicity in patients with advanced colorectal cancer
    Lastraioli, S.
    Ponzanelli, A.
    Leonardi, F.
    Marroni, P.
    Serra, M.
    Sonaglio, C.
    Loiacono, F.
    Zuccaro, D.
    Naldi, N.
    Franzini, E.
    Boni, L.
    Paganuzzi, M.
    Ardizzoni, A.
    Chiara, S.
    Notaro, R.
    ANNALS OF ONCOLOGY, 2006, 17 : XI47 - XI47
  • [23] UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
    Kweekel, D. M.
    Gelderblom, H.
    Van der Straaten, T.
    Antonini, N. F.
    Punt, C. J. A.
    Guchelaar, H-J
    BRITISH JOURNAL OF CANCER, 2008, 99 (02) : 275 - 282
  • [24] UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
    D M Kweekel
    H Gelderblom
    T Van der Straaten
    N F Antonini
    C J A Punt
    H-J Guchelaar
    British Journal of Cancer, 2008, 99 : 275 - 282
  • [25] Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28
    Tian, Chuan
    Ying, Haifeng
    Zhuang, Rongyuan
    Zhang, Xiaowei
    Lu, Hongmin
    Wang, Hui
    Wang, Shuowen
    Li, Qi
    Wang, Chungang
    Cai, Xun
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6217 - 6226
  • [26] Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia
    Teh, L. K.
    Hashim, H.
    Zakaria, Z. A.
    Salleh, M. Z.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 136 (02) : 249 - 259
  • [27] Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Amandito, Radhian
    Rohsiswatmo, Rinawati
    Carolina, Erica
    Maulida, Rizka
    Kresnawati, Windhi
    Malik, Amarila
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [28] UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
    Xu, Chunlei
    Tang, Xushan
    Qu, Yanli
    Keyoumu, Saifuding
    Zhou, Ning
    Tang, Yong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (01) : 119 - 130
  • [29] GILBERT'S SYNDROME, UGT1A1*28 AND BLADDER CANCER
    Longo, Fabrizio
    Biondi, Maria Luisa
    Marotta, Roberta
    Nadry, Hannan
    Mangiarotti, Barbara
    Del Nero, Alberto
    Kartalas-Goumas, Loannis
    Bernardini, Paolo
    Avogadro, Andrea
    Itri, Emanuele
    Mohamed, Yasser
    Hussein, Ismail
    Macchione, Nicola
    Delor, Maurizio
    Varischi, Gaia
    Montanari, Emanuele
    ANTICANCER RESEARCH, 2010, 30 (04) : 1436 - 1436
  • [30] UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
    Chunlei Xu
    Xushan Tang
    Yanli Qu
    Saifuding Keyoumu
    Ning Zhou
    Yong Tang
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 119 - 130
12345